Loading organizations...
Loading organizations...
Biotech company developing precision medicines for cancer treatment.
Treeline Biosciences has raised $200.0M across 1 funding round.
Treeline Biosciences has raised $200.0M in total across 1 funding round.
Treeline Biosciences has raised $200.0M in total across 1 funding round.
Treeline Biosciences's investors include AI Life Sciences, Aisling Capital, Ajax Health, ARCH Venture Partners, Casdin Capital, Exor, Fidelity Management & Research Company, Google Ventures, KKR, OrbiMed, Rock Springs Capital, T. Rowe Price Associates.
Treeline Biosciences has raised $200.0M across 1 funding round. Most recently, it raised $200.0M Series A Extension in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 3, 2025 | $200.0M Series A Extension | AI Life Sciences, Aisling Capital, Ajax Health, ARCH Venture Partners, Casdin Capital, Exor, Fidelity Management & Research Company, Google Ventures, KKR, OrbiMed, Rock Springs Capital, T. Rowe Price Associates |